Companies Dominating the IV Disinfecting Caps Landscape
- Human Metabolome Technologies America Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.   Â
- Bio-Rad Laboratories, Inc.
- Biocrates life sciences AG
- Agilent Technologies, Inc.                      Â
- Merit Medical Systems
- B. Braun Melsungen AG
- ICU Medical, Inc.
- Becton, Dickinson and Company
- 3M Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
IV Disinfecting Caps Market in 2025 is assessed at USD 463 billion.
The global market size was valued at over USD 427.75 billion in 2024 and is expected to expand at a CAGR of around 10.3%, surpassing USD 1.53 trillion revenue by 2037.
North America is projected to deliver USD 535.5 billion by 2037, fueled by an aging population and a growing number of surgeries.
The major players in the market include Human Metabolome Technologies America Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Biocrates life sciences AG, Agilent Technologies, Inc., Merit Medical Systems, B. Braun Melsungen AG, ICU Medical, Inc., Becton, Dickinson and Company, 3M Company
